期刊文献+

别嘌醇致药物超敏反应综合征1例 被引量:2

原文传递
导出
摘要 别嘌醇是黄嘌呤氧化酶抑制剂,通过阻止次黄嘌呤转化为黄嘌呤来减少尿酸合成,临床广泛用于痛风和高尿酸血症的治疗。随着别嘌醇临床应用日益广泛,其引起药物不良反应的报道也逐渐增多,以皮疹最为常见,其发生率高达10%[1],轻者临床表现为麻疹样皮疹或红色斑丘疹,较为严重者则可能出现重症渗出多形性红斑(stevens-johnson syndrome,SJS)、中毒性表皮坏死松懈症(toxic epidermal necrolysis,TEN)。当患者服用别嘌醇后出现以上严重SJS或TEN皮肤不良反应,同时合并明显的血液、肝、肾多器官受累表现时,提示患者发生别嘌醇所致超敏反应综合征(drug-induced hypersensitivity syndrome,DHS)。DHS临床较为罕见,但该病起病凶险,患者临床症状较重,死亡率高。本文报道1例我院别嘌醇引起的DHS。
出处 《中国医院药学杂志》 CAS 北大核心 2017年第12期1213-1214,共2页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献2

二级参考文献25

  • 1Enomoto M, Ochi M, Teramae K, et al. Codeine phosphate-induced hypersensitivity syndrome. Ann Pharmacother, 2004, 38: 799-802.
  • 2Mitani N, Aihara M, Yamakawa Y, et al. Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses. J Med Virol, 2005, 75: 430-434.
  • 3Tohyama M, Yahata Y, Yasukawa M, et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol, 1998, 134:1113-1117.
  • 4Suzuki Y, Inagi R, Aono T, et al. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol, 1998, 134:1108-1112.
  • 5Aihara Y, Ito SI, Kobayashi Y, et al. Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction. Br J Dermatol, 2003, 149: 165-169.
  • 6Hashimoto K, Yasukawa M, Tohyama M. Human herpesvirus 6 and drug allergy. Curt Opin Allergy Clin Immunol, 2003, 3: 255-260.
  • 7Kano Y, Inaoka M, Sakuma K, et al. Virus reactivation and intravenous immunoglobulin ( IVIG ) therapy of drug-induced hypersensitivity syndrome. Toxicology, 2005, 209: 165-167.
  • 8Ohtani T, Hiroi A, Sakurane M, et al. Slow acetylator genotypes as a possible risk factor for infectious mononucleosis-like syndrome induced by salazosulfapyfidine. Br J Dermatol, 2003, 148: 1035-1039.
  • 9Martin AM, Nolan D, Gaudieri S, et al. Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity. Pharmacogenomics, 2004, 5: 643-655.
  • 10Mallal S, Nolan D, Witt C, et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet, 2002, 359:727-732.

共引文献58

同被引文献8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部